is a reputed website selling apple developer account, providing us, China and worldwide developer individual accounts for sale. It's at low price and good quality. Always provides satisfying services!


high quality apple developer account:Factbox: Companies developing mRNA treatments and vaccines


apple developer account

if you want to buy apple account, choose, is a best provider within bussiness for more than 3 years. choose us, you will never regret. we provied worldwide apple developer account for sale.

,The United States has cleared the use of vaccines using messenger RNA (mRNA) to create an immune response from Moderna Inc and partners BioNTech SE and Pfizer Inc, boosting confidence in the novel technology. The following is a list of companies also using mRNA technology to develop treatments and vaccines for diseases including COVID-19: TRANSLATE BIO/SANOFI Translate Bio Inc's lead drug is a cystic fibrosis treatment being tested in early-to-mid stage clinical trials. It is also developing mRNA vaccines for infectious diseases, including COVID-19 and flu, along with Sanofi SA. CUREVAC/GLAXOSMITHKLINE Germany-based CureVac NV is working on mRNA-based vaccines. It has signed a collaboration agreement with GSK to develop vaccines for targeting infectious pathogens. It is also developing a coronavirus vaccine. GRITSTONE/GILEAD Gritstone Oncology Inc has partnered with Gilead Sciences Inc to develop a mRNA based vaccine for the treatment of HIV. BIONTECH Germany's BioNTech is developing mRNA-based therapies for several types of cancer, and vaccines for flu. It has a collaboration in place with the Bill & Melinda Gates Foundation to develop therapies for tuberculosis and HIV. MODERNA In addition to its COVID-19 vaccine, Moderna has signed partnership deals with AstraZeneca Plc, Vertex Pharmaceuticals Inc and Merck & Co to develop mRNA therapeutics. KERNEL BIOLOGICSPrivately-held start-up Kernel is developing mRNA-based immunotherapies for cancer. It has partnered with Boeing and the International Space Station U.S. National Laboratory to launch a study of leukemia therapies to the ISS this year. ARCTURUS Arcturus Therapeutics Inc is developing vaccines for flu and COVID-19, which is in early human testing. It is also testing therapies for cystic fibrosis and heart disease. CureVac last year returned the rights to one drug it was co-developing with the company, but can work with Arcturus on future therapies, under a collaboration deal. ETHRIS/ASTRAZENECA German startup Ethris is developing therapies for severe pulmonary diseases. It is also developing a treatment for asthma and other respiratory diseases along with AstraZeneca, which owns a stake in the company. REUTERS


  • 2021-06-14 00:01:31

    The majority of Australia's near 26 million population will be administered the AstraZeneca vaccine, with 50 million doses set to be produced locally from the end of March. About 2.5 million doses have been locally produced so far with thousands of doses already cleared testing and distributed to the vaccination sites. 我美了美了美了

Popular tags